Westchester and Fairfield County Business Journals covered that Sema4 has hired Dr. William Oh to a newly established position of Chief Medical Science Officer. The story highlights Dr. Oh’s extensive clinical and scientific research expertise, and the critical role he will play as part of Sema4’s senior leadership team.
Lab Manager featured Sema4’s newly built state-of-the-art clinical laboratory in Stamford, CT. Among other things, the article outlines how Sema4 converted a chocolate factory into a lab, navigated COVID-19 during construction, and designed an environmentally friendly workplace.
Dr. William Oh, an internationally recognized medical oncologist, has joined Sema4 as Chief Medical Science Officer. Dr. Oh brings more than 25 years of clinical and translational research experience.
Merus and Sema4 are utilizing Sema4’s genomic testing to identify patients with tumors harboring neuregulin 1 gene fusions who may be eligible for investigational treatment with the bispecific antibody Zenocutuzumab in a trial sponsored by Merus.
Cancer Network conducted a video interview with Sema4 Founder & CEO Eric Schadt. Among other things, Dr. Schadt discusses Sema4’s data-driven precision oncology solutions and the difference they make for healthcare providers and their patients.
The Hartford Business Journal covered BioCT’s naming Sema4 Founder & CEO Eric Schadt as its 2020 Entrepreneur of the Year. The story highlighted Sema4’s growth as a key winning factor for the recognition and provided more background information on the award.
Clinical OMICs published an extensive Q&A featuring Eric Schadt, Founder and CEO of Sema4. The article covers the origins of Sema4, the company’s current priorities, its focus on data-driven solutions to improve health outcomes, and more.
Westchester and Fairfield County Business Journals highlighted Sema4’s opening of its second clinical laboratory in Connecticut. The outlet noted that the new lab will support customers’ genomic testing needs and expand the company’s digital health services, will enable Sema4 to perform scientific research, and will create hundreds of jobs.
The Hartford Courant covered Sema4’s announcement on its opening of its newly built clinical laboratory in Connecticut. The feature story profiled Sema4’s continued expansion, the surge in demand for data-driven healthcare, and more.
NBC Connecticut interviewed Sema4 President & COO Jamie Coffin on the opening of Sema4’s new 70,000 square foot facility in Stamford, CT. Among other things, the story covered Sema4’s growth and the jobs the company is generating in Connecticut.